TF_Arusha_Jun10/1 Framework for Evaluation of Male Circumcision Devices Tim Farley Department of Reproductive Health and Research World Health Organization.

Slides:



Advertisements
Similar presentations
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
Advertisements

Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
National AIDS/STD Control Programme Ministry of Health, Kenya and Ministry of Medical Services, Kenya Pilot Study of the Shang Ring: A Novel Male Circumcision.
The U.S. Presidents Emergency Plan for AIDS Relief Title The U.S Presidents Emergency Plan for AIDS Relief PEPFAR Male Circumcision Technical Working Group.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Donald T. Simeon Caribbean Health Research Council
Bill & Melinda Gates Foundation Male Circumcision funding Heather Harrison WHO meeting June, 2010.
1 GRS and Accreditation March Learning objectives After reviewing this presentation, you will understand  How the Global Rating Scale supports.
Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
Prevention and Management of Sexually Transmitted Diseases in Persons Living with HIV/AIDS Partner Management.
MANUALS for DEVELOPING EYE HEALTH INTERVENTIONS
Dr. ABDULLAH ABDU ALMIKHLAFY Assistant professor & Head of community medicine department Presented By University of Science & Technology Sana’a – Yemen.
Comparison Study of EIMC Devices and Pilot Implementation in Botswana Rebeca M. Plank, MD MPH Brigham and Women’s Hospital / Botswana-Harvard School of.
Teenage conceptions in Wales The challenge of intervention and evaluation.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
Put a Ring on it: How the Shang Ring Might Accelerate MC Programs
© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.
Risk Management and Strategy Prioritisation Intelligence Step 8 - Risk Management and Strategy Prioritisaiton Considering the risks associated with action.
Guidance for Industry Establishing Pregnancy Registries Pregnancy Registry Working Group Pregnancy Labeling Taskforce March, 2000 Evelyn M. Rodriguez M.D.,
Benefits for using a standardised risk management framework to risk assess Infection Prevention and Control Sue Greig Senior Project Officer National.
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
 Rwanda national goal: VMMC to 2 million men in 2 years to decrease HIV incidence by 50%; attainable only if task shifting is possible to nurses, as.
Ensuring the Fundamentals of Care in Family Planning and Reproductive Health Services MODULE 2 Facilitative Supervision for Quality Improvement Curriculum.
Introduction to Devices for VMMC: Potential to Accelerate Scale-up, Approval Processes, and Status of Clinical Trials Jason Reed, MD, MPH Sr. Technical.
Scaling-up male circumcision programmes in the Eastern and Southern Africa region Country Update Meeting June 2010 Dr Sibongile Dludlu UNAIDS RST/ESA.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Health Technologies Adoption Programme Stephen Hodges – Technology Implementation Manager.
How to use the EFQM Excellence Model to empower patients and staff create a latex- safe environment Karen Cunningham Health & Safety Manager Musgrave Park.
The MARYLAND HEALTH CARE COMMISSION. Telehealth Landscape Telehealth adoption is increasing 2013: ~ 61 percent of acute care hospitals; ~9 percent of.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region: Country update meeting Dr David Linyama UTH.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting HIV Testing and Counseling and Male Circumcision.
Progress to date and Plans for Year 5 Overcoming HIV/AIDS epidemic in Ukraine Programme supported by the Global Fund 11 th Stakeholders’ meeting 22 nd.
NORTH AMERICAN HEALTHCARE COMMITTEES. POLICY Facility shall have at least the following committees: Resident Care Infection Control Pharmaceutical Quality.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
Overview of MC Research in Kenya Country Update Meeting on MC Scale Up Eastern and Southern Africa Region, Arusha Dr Mores Loolpapit BSc, MB ChB, MPH 10.
UNDERSTANDING AND DEFINING QUALITY Quality Academy – Cohort 6 April 8, 2013.
Translation of research data into programmes and practice: UN Work Plan on Male Circumcision Translation of research data into programmes and practice:
Quality of Voluntary Medical Male Circumcision Services during Scale-Up: A Comparative Process Evaluation in Kenya, South Africa, Tanzania and Zimbabwe.
EngenderHealth’s Work on Male Circumcision
The Cost and Impact of Scaling-up Medical Male Circumcision in Uganda: An Empirical Analysis International AIDS Conference Vienna July 2010 Nazarius Mbona.
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS Safety concerns facing health care systems today.
Update on Male Circumcision Programme Presented By: Sinokuthemba Xaba National MC Focal Person/AIDS & TB Unit MOHCW 8-10 June 2010 Zimbabwe Country Presentation.
1 5 th World Conference on Virology, December th 2015, Atlanta,USA Chaste KARANGWA 1, Eugene RUGIRA 1, Placidie MUGWANEZA 1, Helene Badini 3, Fabian.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
TF_DEL_Oct07/1 Microbicide Trials – Role of Data and Safety Monitoring Boards Tim Farley Department of Reproductive Health and Research World Health Organization.
Background The United Kingdom Department of Health introduced single-use instruments (SUI) for tonsil and adenoid surgery in January 2001, based on the.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Context and Problem Effects of Changes Strategy for Change Aim: To reduce the length of handover by standardising the quality of information transmitted.
Auditing ISO Nancy Pasquan November Introductions I am….. You are….. And we are here to discuss: Auditing ISO Quality Systems for Medical.
Study Report HIV Prevention: One Arm, Open Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Scale Up of.
VMMC Sustainability and Early Infant Male Circumcision Dr. Tin Tin Sint HIV section, UNICEF New York.
Title of the Change Project
Dr. Kęstutis Adamonis, Dr. Romanas Zykus,
Designing Effective Accommodation Plans in Clinical Placement & Internship Settings
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
Contact: Robert Safety of a facility-based versus community-based model of early infant male circumcision using the Mogen clamp.
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.
WHO, UNICEF, UNFPA, UNESCO & GNP+
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS
Safety plan.
Assigning Risk Categories to Patients
Chapter 20 Evaluation Evaluation is the final step of the nursing process. In this step you determine if your client’s condition or well- being has improved.
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

TF_Arusha_Jun10/1 Framework for Evaluation of Male Circumcision Devices Tim Farley Department of Reproductive Health and Research World Health Organization Geneva

TF_Arusha_Jun10/2 The Challenge Male circumcision devices have potential to accelerate programme scale up Potentially – Faster, simpler procedure – Less highly-trained providers – More acceptable Several devices used and well-documented in infants and boys, but safety, effectiveness, acceptability among adults in Africa not known

TF_Arusha_Jun10/3 Progression of Clinical Studies Clinical studies by skilled surgeons in the country of origin or manufacture, Clinical studies by skilled surgeons in the country of intended use, Comparative clinical study by skilled surgeons in a low resource setting, and Field studies by trained clinical personnel in a low resource setting, reflecting anticipated conditions of intended use.

TF_Arusha_Jun10/4 Framework for Evaluation of Devices Compilation of manufacturing, performance and clinical experience in country of origin – Case-series plus comparative study – Safety, effectiveness, document potential advantages, generate data independent of developer or manufacturer Studies in country of intended final use – Case series, comparative study, acceptability, field study, post-marketing surveillance

TF_Arusha_Jun10/5 Male Circumcision Devices Consultation Nairobi, March 2009

TF_Arusha_Jun10/6 Conclusions and Recommendations Male circumcision devices have potential to accelerate programme scale up and expansion to areas not well served by existing surgical services. While circumcision devices have been successfully used in other populations, experience with their use among adults in Africa has not been encouraging. It is important to proceed in a cautious yet progressive fashion, ensuring that the safety, effectiveness and acceptability of the devices in populations with good access to care are established before proceeding to more widespread implementation.

TF_Arusha_Jun10/7 Conclusions and Recommendations Since male circumcision is being implemented as a public health intervention for HIV prevention among healthy men, it is important to proceed cautiously and avoid any major complications or adverse events. Public acceptance of circumcision devices and confidence in the male circumcision programme could easily be undermined if adverse events occur and are widely publicized.

TF_Arusha_Jun10/8 Conclusions and Recommendations Requirements outlined for evaluation of male circumcision devices are more stringent than requirements for registration of medical devices that present minimal risks to the provider or patient. However, the desired end result is to ensure that safe, effective and acceptable devices could be introduced rapidly into national programmes. This requires more extensive data on clinical experience and acceptability than required for a device to be authorized for distribution in the country. Preliminary data on the Shang Ring device developed in China are encouraging and the device should be tested in a progressive manner in men in Africa.

TF_Arusha_Jun10/9 Conclusions and Recommendations Critical steps in testing new devices in new populations were agreed and summarized for incorporation into the Framework for Evaluation of Devices for Adult Male Circumcision that will be updated. Other technologies that might accelerate male circumcision service delivery should be considered in addition to circumcision devices, though no cost-effective innovations had been identified to date. These should be evaluated in a progressive manner, considering the advantages and potential risks associated with their use.